Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Prior Art - Discovery
BaNos and All... a R/S wouldn't help unless we had an increasing revenue stream, preferably multiple streams, that could support the stock. As it stands now we just don't know when our next licensee will be signed. Not enough substance to the company yet to justify a r/s IMO. Maybe after a successful resolution of the J3.
Share
New Message
Please login to post a reply